NEULANDLAB Neuland Laboratories Limited
Healthcare
LTP
19,700
CHG · %
-83 (-0.42%)
VOL · TODAY
61.32K
PREV CLOSE
19,783
Today's range19,205 · 19,750
19,700
52-week range11,500 · 24,225
19,700
Loading candles…
Neuland Laboratories Limited operates in the pharmaceutical and chemical industries, specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) as well as providing Contract Development and Manufacturing Organization (CDMO) services. The company serves both domestic and international markets, distributing products in over 80 countries. Its business segments include Generic APIs (GDS) and Custom Manufacturing Solutions (CMS). Neuland Laboratories offers end-to-end solutions that span from pre-investigational new drug (pre-IND) stages through commercial supply. The company emphasizes adherence to high-quality standards and regulatory compliance across a range of therapeutic areas. No information is provided regarding the company's year of incorporation, founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for NEULAND LAB LTD. (NEULANDLAB) on the NSE. As a listed security, NEULAND LAB LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NEULANDLAB before placing trades on tick2trade.
As of the latest feed, NEULANDLAB last traded at ₹19,700 on NSE, down ₹83 (0.42%) from the previous close of ₹19,783. Today's session range is ₹19,205 – ₹19,750, against a 52-week band of ₹11,500 – ₹24,225. Traded volume today stands at 61.32K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for NEULANDLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NEULANDLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NEULAND LAB LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NEULANDLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NEULANDLAB option chain page linked from this overview.
// similar in healthcare326 total